These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 5359756)
21. [Ultrastructural study of ocular pigmentation due to phenothiazines]. Sizaret P; Rossazza C; Brassart B Rev Otoneuroophtalmol; 1975; 47(4):247-51. PubMed ID: 1215727 [No Abstract] [Full Text] [Related]
22. Ocular complications of phenothiazines. Mathalone MB Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613 [No Abstract] [Full Text] [Related]
23. [Experimentation with 1317 AN]. Vayron de la Moureyre D; Lehembre P Lille Med; 1970 Jan; 15():180-3. PubMed ID: 5437222 [No Abstract] [Full Text] [Related]
24. An adverse reaction unit: results and functions. Ananth JV; Ban TA; Lehmann HE; Rizvi FA Am J Psychiatry; 1971 Apr; 127(10):1339-44. PubMed ID: 5092571 [No Abstract] [Full Text] [Related]
25. [Adverse effects of phenothiazines]. Roos BE Nord Psykiatr Tidsskr; 1968; 22(2):97-100. PubMed ID: 5704635 [No Abstract] [Full Text] [Related]
26. Prognosis of eye complications caused by phenothiazines. Forrest FM; Snow HL Dis Nerv Syst; 1968 Mar; 29(3):Suppl:26-8. PubMed ID: 5672560 [No Abstract] [Full Text] [Related]
27. [First clinical trails with the "medium tranquilizer" mesoridazine]. Rhomberg F; Staehelin B Schweiz Med Wochenschr; 1967 Apr; 97(16):521-5. PubMed ID: 4875573 [No Abstract] [Full Text] [Related]
28. [Result of premidecation in the psychic sedation if patients]. Slijepcević S Anaesthesist; 1968 Feb; 17(2):39-42. PubMed ID: 5726431 [No Abstract] [Full Text] [Related]
29. [Characteristics of phenothiazine pigmentation of the skin]. Lipets ME; Shibaeva LN; Kurenkova NM Klin Med (Mosk); 1973 Jul; 51(7):118-20. PubMed ID: 4786249 [No Abstract] [Full Text] [Related]
31. [Ocular disorders during treatment with neuroleptics and thymoleptics]. Cuendet JF; Verrey F; Nouri A; Rosselet E; Faggioni R Bull Soc Belge Ophtalmol; 1972; 160(2):601-6. PubMed ID: 4656814 [No Abstract] [Full Text] [Related]
32. Drug induced retinopathy. Meier-Ruge W Ophthalmologica; 1969; 158 Suppl():561-73. PubMed ID: 4902422 [No Abstract] [Full Text] [Related]
33. Long-acting tranquillizers. Johnson DA; Freeman H Practitioner; 1972 Mar; 208(245):395-400. PubMed ID: 5025560 [No Abstract] [Full Text] [Related]
34. [On the development of leukopenia and agranulocytosis during therapy with preparaions of the phenothiazine series]. Rubinshteĭn AIu Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1548-50. PubMed ID: 6000318 [No Abstract] [Full Text] [Related]
35. [Facial dyskinesias caused by phenothiazine derivatives]. De Oya JC; Alvarez Prechous A; Del Río A; Noya M; Ansede A Rev Clin Esp; 1971 May; 121(4):357-60. PubMed ID: 5563111 [No Abstract] [Full Text] [Related]
36. Phenothiazine toxicity in paediatric practice with three case reports. Bajpai PC; Sethi VK; Pathak AK; Tripathi TK Indian Pediatr; 1969 Jul; 6(7):470-5. PubMed ID: 5345025 [No Abstract] [Full Text] [Related]
37. Phenothiazines and diabetes in hospitalized women. Thonnard-Neumann E Am J Psychiatry; 1968 Jan; 124(7):978-82. PubMed ID: 5634402 [No Abstract] [Full Text] [Related]